• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2101397 SHR2285片 SHR2285 Tablet Chemical Drugs(1) New Drug Application 2021-08-13 Shanghai Hengrui Pharmaceutical Co Ltd view
CXHL1800158 SHR2285片 SHR2285 Tablet Chemical Drugs(1) New Drug Application 2018-09-14 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2018-09-12 view
CXHL1800157 SHR2285片 SHR2285 Tablet Chemical Drugs(1) New Drug Application 2018-09-14 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2018-09-12 view
CXHB2100050 SHR2285片 SHR2285 Tablet Chemical Drugs(1) Supplementary Application 2021-03-30 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2021-03-29 view
CXHB2100049 SHR2285片 SHR2285 Tablet Chemical Drugs(1) Supplementary Application 2021-03-30 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2021-03-29 view
CXHB2000018 SHR2285片 SHR2285 Tablet Chemical Drugs Supplementary Application 2020-04-24 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2020-04-23 view
CXHB2000017 SHR2285片 SHR2285 Tablet Chemical Drugs Supplementary Application 2020-03-21 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2020-03-20 view
CXHB1900013 SHR2285片 SHR2285 Tablet Chemical Drugs Supplementary Application 2019-04-10 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2019-04-09 view
CXHB1900012 SHR2285片 SHR2285 Tablet Chemical Drugs Supplementary Application 2019-04-10 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd In Review 2019-04-09 view